Julie Kanter - Concepedia

Author

Julie Kanter

University of Alabama at Birmingham ORCID

Also Known As

Cancado, Rodolfo, F.J. Ogunsile, J Kanter, J. Kanter, Joseph A. Jakubowski, Julie Kanter, KANTER J., Nieder, Michael

311

Publications

6.8K

Citations

H-Index

130

Concepts

All Affiliations

University of Alabama at Birmingham Medical University of South Carolina UCSF Benioff Children's Hospital Washington University in St. Louis Emory University

About

Julie Kanter is an author at University of Alabama at Birmingham specializing in medicine, hematology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	924
2	Health Sciences	5	5	210
3	Arts	1	1	11
4	Engineering	1	1	83
5	Nursing	1	1	13

Julie Kanter

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease Kenneth I. Ataga, Abdullah Kutlar, Julie Kanter, New England Journal of Medicine	2016	837
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga, New England Journal of Medicine	2019	581
A Phase 3 Trial of <scp>l</scp> -Glutamine in Sickle Cell Disease Yutaka Niihara, Scott T. Miller, Julie Kanter, New England Journal of Medicine	2018	522
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia Vivek Patel, Matthieu Mahévas, Soo Yong Lee, Blood	2012	337
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab Rebecca Marsh, Carl E. Allen, Kenneth L. McClain, Pediatric Blood & Cancer	2012	302
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study Mary Eapen, Ruta Brazauskas, Mark C. Walters, The Lancet Haematology TransplantationSickle Cell DiseaseHematologyGraft SurvivalBlood Transplantation	2019	192
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events Matthew M. Heeney, Carolyn Hoppe, Miguel R. Abboud, New England Journal of Medicine	2015	141
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease Matthew M. Hsieh, Melissa Bonner, Francis J. Pierciey, Blood Advances Primary ImmunodeficiencyHematological MalignancyGene TherapiesSickle Cell DiseaseNovel Treatments	2020	139
Density-based separation in multiphase systems provides a simple method to identify sickle cell disease Ashok A. Kumar, Matthew R. Patton, Jonathan W. Hennek, Proceedings of the National Academy of Sciences	2014	122
Validation of a novel point of care testing device for sickle cell disease Julie Kanter, Marilyn J. Telen, Carolyn Hoppe, BMC Medicine	2015	113

Page 1